top of page
Mother in army uniform and daughter in the street_edited.jpg

Committed to ensuring patients have access to the therapies they need.

Revolve Access is a consulting firm specializing in market entry and growth strategies that achieve a balance between patient access and business opportunity.

ABOUT

We Create Market Events.

Revolve proactively creates and facilitates strategic opportunities because the current market demands it. Analogs of success, predictive analytics and a path to contain ROI are crucial in a highly consolidated access landscape. 

White round tablet with two pills in background_edited.jpg
The United States Capitol building with the dome lit up at night USA_edited.jpg

WHY REVOLVE

Our Core Differentiator

Revolve is comprised of former government health system decision makers and biopharma executives who understand how to optimize federal market outcomes while ensuring regulatory obligations are met.

Team highlights include:

Former VA and DoD Chief Pharmacists and with access to key health system decision makers and KOL’s.

Extensive experience effectively launching, re-positioning and promoting a variety of product types.

Expertise in providing predictive analytics, contract scenario modeling, and negotiation strategy unique to federal controls and limitations.

Capable of designing business strategies and implementing them on behalf of our clients.

Team

LAUNCH

PLANNING & READINESS 
TRAINING PROGRAMS
BRAND VALUE MESSAGING
PRE-APPROVAL INFORMATION EXCHANGE

MARKET DIFFUSION ANALYSIS
CONTRACTING & PRICING

 

GROW

MARKET RESEARCH
IDEATION WORKSHOPS
MARKET CONFIRMATION STRATEGIES
SEGMENTATION TARGETING
BRAND VALUE RESET
ACCOUNT EXECUTIVE SUPPORT

 Strategy Consulting

Account Engagement

Navigate uncertainty and create sustained value with an intensely customer-focused approach

Accelerate market impact leveraging our established trust as a force multiplier.

How We Help

CLIENTS

BioPharma

Large, Mid & Small-Cap Pharma

Biosimilars, New Launch

Specialty, Rare Disease, Cell/Gene

Biosimilars, Mature Brands

Device

Medical Equipment & Med/Surg Supplies

Surgical Implants & External Device

Med Tech, Diagnostics

Others 

Private Equity & VC

Hospital Dealers & Resellers

OTC, PPE & Supplements

GSA Schedules

vials with a vaccine and a syringe on a white background..jpg

Recommended Insights

01.

Genomics

Personalized Medicine in the Department of Veterans Affairs

03.

Launch 

Federal Launch Checklist - 

VA / DoD Market Entry Roadmap 

05.

Contracting  

National Contract Bid Strategy Considerations

02.

Landscape 

Understanding Federal Market Dynamics 

04.

Spillover 

Federal Market Diffusion Analysis - How it Works

06.

PGx

Pharmacogenomics (PGx) in the Department of Veterans Affairs

bottom of page